Lifevantage Corporation (NASDAQ:LFVN) Plans Quarterly Dividend of $0.05

Lifevantage Corporation (NASDAQ:LFVNGet Free Report) declared a quarterly dividend on Wednesday, May 6th. Stockholders of record on Monday, June 1st will be given a dividend of 0.05 per share on Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date is Monday, June 1st. This is a 11.1% increase from Lifevantage’s previous quarterly dividend of $0.05.

Lifevantage has a dividend payout ratio of 16.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Lifevantage to earn $0.70 per share next year, which means the company should continue to be able to cover its $0.18 annual dividend with an expected future payout ratio of 25.7%.

Lifevantage Trading Down 16.6%

Shares of NASDAQ:LFVN traded down $1.00 on Thursday, reaching $5.01. 365,799 shares of the company were exchanged, compared to its average volume of 201,328. Lifevantage has a 1-year low of $3.90 and a 1-year high of $15.00. The firm has a market cap of $64.11 million, a price-to-earnings ratio of 8.35 and a beta of 0.52. The company has a 50-day moving average of $4.70 and a 200-day moving average of $5.81.

Lifevantage (NASDAQ:LFVNGet Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). The company had revenue of $43.72 million for the quarter, compared to analyst estimates of $47.77 million. Lifevantage had a return on equity of 29.59% and a net margin of 3.74%. As a group, analysts forecast that Lifevantage will post 0.65 earnings per share for the current year.

About Lifevantage

(Get Free Report)

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

See Also

Dividend History for Lifevantage (NASDAQ:LFVN)

Receive News & Ratings for Lifevantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifevantage and related companies with MarketBeat.com's FREE daily email newsletter.